TY - JOUR
T1 - Preoperative Brain Tumor Imaging
T2 - Models and Software for Segmentation and Standardized Reporting
AU - Bouget, David
AU - Pedersen, André
AU - Jakola, Asgeir S.
AU - Kavouridis, Vasileios
AU - Emblem, Kyrre E.
AU - Eijgelaar, Roelant S.
AU - Kommers, Ivar
AU - Ardon, Hilko
AU - Barkhof, Frederik
AU - Bello, Lorenzo
AU - Berger, Mitchel S.
AU - Conti Nibali, Marco
AU - Furtner, Julia
AU - Hervey-Jumper, Shawn
AU - Idema, Albert J.S.
AU - Kiesel, Barbara
AU - Kloet, Alfred
AU - Mandonnet, Emmanuel
AU - Müller, Domenique M.J.
AU - Robe, Pierre A.
AU - Rossi, Marco
AU - Sciortino, Tommaso
AU - Van den Brink, Wimar A.
AU - Wagemakers, Michiel
AU - Widhalm, Georg
AU - Witte, Marnix G.
AU - Zwinderman, Aeilko H.
AU - De Witt Hamer, Philip C.
AU - Solheim, Ole
AU - Reinertsen, Ingerid
N1 - Funding Information:
Data were processed in digital labs at HUNT Cloud, Norwegian University of Science and Technology, Trondheim, Norway.
Funding Information:
This study was funded by the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy ( usigt.org ); South-Eastern Norway Regional Health Authority; Contract Grant Nos. 2016102 and 2013069; Contract grant sponsor: Research Council of Norway; Contract Grant No. 261984; Contract grant sponsor: Norwegian Cancer Society; Contract Grant Nos. 6817564 and 3434180; Contract grant sponsor: European Research Council under the European Union's Horizon 2020 Program; Contract Grant No. 758657-ImPRESS; an unrestricted grant of Stichting Hanarth fonds, Machine learning for better neurosurgical decisions in patients with glioblastoma; a grant for public-private partnerships (Amsterdam UMC PPP-grant) sponsored by the Dutch government (Ministry of Economic Affairs) through the Rijksdienst voor Ondernemend Nederland (RVO) and Topsector Life Sciences and Health (LSH), Picturing predictions for patients with brain tumors; a grant from the Innovative Medical Devices Initiative program, project number 10-10400-96-14003; The Netherlands Organisation for Scientific Research (NWO), 2020.027; a grant from the Dutch Cancer Society, VU2014-7113; the Anita Veldman foundation, CCA2018-2-17. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Publisher Copyright:
Copyright © 2022 Bouget, Pedersen, Jakola, Kavouridis, Emblem, Eijgelaar, Kommers, Ardon, Barkhof, Bello, Berger, Conti Nibali, Furtner, Hervey-Jumper, Idema, Kiesel, Kloet, Mandonnet, Müller, Robe, Rossi, Sciortino, Van den Brink, Wagemakers, Widhalm, Witte, Zwinderman, De Witt Hamer, Solheim and Reinertsen.
PY - 2022/7/27
Y1 - 2022/7/27
N2 - For patients suffering from brain tumor, prognosis estimation and treatment decisions are made by a multidisciplinary team based on a set of preoperative MR scans. Currently, the lack of standardized and automatic methods for tumor detection and generation of clinical reports, incorporating a wide range of tumor characteristics, represents a major hurdle. In this study, we investigate the most occurring brain tumor types: glioblastomas, lower grade gliomas, meningiomas, and metastases, through four cohorts of up to 4,000 patients. Tumor segmentation models were trained using the AGU-Net architecture with different preprocessing steps and protocols. Segmentation performances were assessed in-depth using a wide-range of voxel and patient-wise metrics covering volume, distance, and probabilistic aspects. Finally, two software solutions have been developed, enabling an easy use of the trained models and standardized generation of clinical reports: Raidionics and Raidionics-Slicer. Segmentation performances were quite homogeneous across the four different brain tumor types, with an average true positive Dice ranging between 80 and 90%, patient-wise recall between 88 and 98%, and patient-wise precision around 95%. In conjunction to Dice, the identified most relevant other metrics were the relative absolute volume difference, the variation of information, and the Hausdorff, Mahalanobis, and object average symmetric surface distances. With our Raidionics software, running on a desktop computer with CPU support, tumor segmentation can be performed in 16–54 s depending on the dimensions of the MRI volume. For the generation of a standardized clinical report, including the tumor segmentation and features computation, 5–15 min are necessary. All trained models have been made open-access together with the source code for both software solutions and validation metrics computation. In the future, a method to convert results from a set of metrics into a final single score would be highly desirable for easier ranking across trained models. In addition, an automatic classification of the brain tumor type would be necessary to replace manual user input. Finally, the inclusion of post-operative segmentation in both software solutions will be key for generating complete post-operative standardized clinical reports.
AB - For patients suffering from brain tumor, prognosis estimation and treatment decisions are made by a multidisciplinary team based on a set of preoperative MR scans. Currently, the lack of standardized and automatic methods for tumor detection and generation of clinical reports, incorporating a wide range of tumor characteristics, represents a major hurdle. In this study, we investigate the most occurring brain tumor types: glioblastomas, lower grade gliomas, meningiomas, and metastases, through four cohorts of up to 4,000 patients. Tumor segmentation models were trained using the AGU-Net architecture with different preprocessing steps and protocols. Segmentation performances were assessed in-depth using a wide-range of voxel and patient-wise metrics covering volume, distance, and probabilistic aspects. Finally, two software solutions have been developed, enabling an easy use of the trained models and standardized generation of clinical reports: Raidionics and Raidionics-Slicer. Segmentation performances were quite homogeneous across the four different brain tumor types, with an average true positive Dice ranging between 80 and 90%, patient-wise recall between 88 and 98%, and patient-wise precision around 95%. In conjunction to Dice, the identified most relevant other metrics were the relative absolute volume difference, the variation of information, and the Hausdorff, Mahalanobis, and object average symmetric surface distances. With our Raidionics software, running on a desktop computer with CPU support, tumor segmentation can be performed in 16–54 s depending on the dimensions of the MRI volume. For the generation of a standardized clinical report, including the tumor segmentation and features computation, 5–15 min are necessary. All trained models have been made open-access together with the source code for both software solutions and validation metrics computation. In the future, a method to convert results from a set of metrics into a final single score would be highly desirable for easier ranking across trained models. In addition, an automatic classification of the brain tumor type would be necessary to replace manual user input. Finally, the inclusion of post-operative segmentation in both software solutions will be key for generating complete post-operative standardized clinical reports.
KW - 3D segmentation
KW - deep learning
KW - glioma
KW - meningioma
KW - metastasis
KW - MRI
KW - open-source software
KW - RADS
UR - http://www.scopus.com/inward/record.url?scp=85139444561&partnerID=8YFLogxK
U2 - 10.3389/fneur.2022.932219
DO - 10.3389/fneur.2022.932219
M3 - Article
AN - SCOPUS:85139444561
SN - 1664-2295
VL - 13
JO - Frontiers in Neurology
JF - Frontiers in Neurology
M1 - 932219
ER -